Annexon, Inc.(ANNX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ANNX Annexon, Inc.

交易中 11-22 10:57:17 EST

5.25

+0.08

+1.55%

最高5.32	最低5.08	成交量29.75万
今开5.20	昨收5.17	日振幅4.64%
总市值5.60亿	流通市值3.70亿	总股本1.07亿
成交额155.88万	换手率0.42%	流通股本7,051万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ANNX","market":"US","secType":"STK","nameCN":"Annexon, Inc.","latestPrice":5.25,"timestamp":1732291028375,"preClose":5.17,"halted":0,"volume":297512,"delay":0,"floatShares":70511273,"shares":106593505,"eps":-0.997706,"marketStatus":"交易中","marketStatusCode":2,"change":0.08,"latestTime":"11-22 10:57:17 EST","open":5.2,"high":5.32,"low":5.08,"amount":1558821.264288,"amplitude":0.046422,"askPrice":5.26,"askSize":217,"bidPrice":5.24,"bidSize":1110,"shortable":3,"etf":0,"ttmEps":-0.997706,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1732309200000},"adr":0,"listingDate":1595563200000,"adjPreClose":5.17,"preHourTrading":{"tag":"盘前","latestPrice":5.25,"preClose":5.17,"latestTime":"09:28 EST","volume":1687,"amount":8772.540021,"timestamp":1732285680086},"postHourTrading":{"tag":"盘后","latestPrice":5.18,"preClose":5.17,"latestTime":"19:56 EST","volume":25846,"amount":133663.2503,"timestamp":1732236991797},"volumeRatio":0.750079,"impliedVol":0.8972,"impliedVolPercentile":0.381},"requestUrl":"/m/hq/s/ANNX/wiki","defaultTab":"wiki","newsList":[{"id":"1112798905","title":"异动解读 | Annexon股价盘中大涨5.23% 研究主题获监管机构批准或是主因","url":"https://stock-news.laohu8.com/highlight/detail?id=1112798905","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1112798905?lang=zh_cn&edition=full","pubTime":"2024-11-22 01:24","pubTimestamp":1732209861,"startTime":"0","endTime":"0","summary":"生物制药公司Annexon(ANNX)今日盘中大涨5.23%,引起市场广泛关注。\n分析人士认为,导致该股大涨的可能原因是该公司的研究主题获得了监管机构的批准。Annexon专注于为自身免疫疾病和神经退行性疾病患者开发治疗药物,其候选药物包括ANX005、ANX007、ANX1502和ANX009等,覆盖了多个领域。如果这些药物获批上市,将为公司带来巨大收益。\n市场分析师普遍看好该公司的发展前景。机构评级显示,有8家机构参与评级,其中100%给予该公司\"买入\"评级。这表明分析师对Annexon研发实力和产品前景十分看好。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | Annexon股价盘中大涨5.23% 研究主题获监管机构批准或是主因","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ANNX"],"gpt_icon":0},{"id":"2485410885","title":"Annexon, Inc.盘中异动 股价大涨5.04%报5.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485410885","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485410885?lang=zh_cn&edition=full","pubTime":"2024-11-22 01:19","pubTimestamp":1732209564,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日01时19分，Annexon, Inc.股票出现波动，股价快速上涨5.04%。截至发稿，该股报5.42美元/股，成交量104.043万股，换手率0.98%，振幅6.78%。Annexon, Inc.股票所在的生物技术行业中，整体涨幅为0.16%。Annexon, Inc.公司简介：Annexon Inc 是一家处于临床阶段的生物制药公司，为身体，大脑和眼部经典补体介导疾病患者开发新型疗法产品线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122011925971a7eea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122011925971a7eea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANNX","BK4139"],"gpt_icon":0},{"id":"1167636290","title":"异动解读 | Annexon, Inc.(ANNX)盘中大跌5.31%,分析师下调目标价引发担忧","url":"https://stock-news.laohu8.com/highlight/detail?id=1167636290","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1167636290?lang=zh_cn&edition=full","pubTime":"2024-11-20 23:24","pubTimestamp":1732116264,"startTime":"0","endTime":"0","summary":"Annexon, Inc.(ANNX)股价今日盘中出现大幅下跌,跌幅达到5.31%。这一下跌引发了市场的广泛关注。\n\n消息面上,分析师机构摩根大通将该公司目标价从11美元下调至9美元。这一调低目标价的行为,引发了市场对公司前景的担忧,导致投资者纷纷抛售该股股票,从而引发了股价的大幅下挫。\n\nAnnexon, Inc.是一家生物制药公司,专注于开发新型治疗经典补体介导疾病药物。虽然目前公司尚无营收,但其产品线备受市场关注。分析师下调目标价或将加剧投资者对公司前景的担忧,这可能是推动今日股价下跌的主要原因。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"异动解读 | Annexon, Inc.(ANNX)盘中大跌5.31%,分析师下调目标价引发担忧","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ANNX"],"gpt_icon":0},{"id":"2484314324","title":"Annexon, Inc.盘中异动 早盘大幅下挫5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484314324","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484314324?lang=zh_cn&edition=full","pubTime":"2024-11-20 23:17","pubTimestamp":1732115875,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日23时17分，Annexon, Inc.股票出现波动，股价大幅跳水5.04%。Annexon, Inc.股票所在的生物技术行业中，整体涨幅为0.31%。Annexon, Inc.公司简介：Annexon Inc 是一家处于临床阶段的生物制药公司，为身体，大脑和眼部经典补体介导疾病患者开发新型疗法产品线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120231755a248d8ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120231755a248d8ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANNX","BK4139"],"gpt_icon":0},{"id":"2484715456","title":"美国研究综述-Apellis Pharmaceuticals、Energizer Holdings、沃尔玛","url":"https://stock-news.laohu8.com/highlight/detail?id=2484715456","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484715456?lang=zh_cn&edition=full","pubTime":"2024-11-20 14:56","pubTimestamp":1732085774,"startTime":"0","endTime":"0","summary":"    路透11月20日 - 华尔街证券分析师周三调整了对几家美国上市公司的评级和目标价，其中包括 Apellis Pharmaceuticals、Energizer Holdings 和沃尔玛。要闻              * Apellis Pharmaceuticals Inc   ：摩根大通将目标价从57美元下调至50美元             * Chord Energy Corp   ：加拿大皇家银行将目标价从185美元下调至180美元             * Energizer Holdings Inc   ：摩根大通将其评级从 \"减持 \"上调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PIII","BBIO","LU1988902786.USD","LU2756315318.SGD","FSUN","BK4528","IE00B19Z8X17.USD","NUVL","LU0528227936.USD","BK4596","DYN","ENR","LOW","TVTX","BK4505","VVV","LU0265550946.USD","BK4187","CASY","IE00BZ1G4Q59.USD","ANNX","ABUS","NOG","OCSL","BRBR","BERY","MNPR","CHRD","BK4086","LU0310799852.SGD","CRM","AZEK","LU2430703251.USD","LU1066053197.SGD","LU2286300806.USD","LH","PBF","WMT","APLS","SWTX","LU0006061336.USD","VIR","OLMA","LU1267930490.SGD","LU1951198990.SGD","IIIV","BK4579","VERA","AVAV","LU1551013425.SGD"],"gpt_icon":0},{"id":"2484677125","title":"Annexon, Inc.盘中异动 股价大跌5.07%报5.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484677125","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484677125?lang=zh_cn&edition=full","pubTime":"2024-11-18 23:27","pubTimestamp":1731943651,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日23时27分，Annexon, Inc.股票出现波动，股价急速跳水5.07%。截至发稿，该股报5.81美元/股，成交量33.947万股，换手率0.32%，振幅6.37%。Annexon, Inc.股票所在的生物技术行业中，整体跌幅为0.28%。Annexon, Inc.公司简介：Annexon Inc 是一家处于临床阶段的生物制药公司，为身体，大脑和眼部经典补体介导疾病患者开发新型疗法产品线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118232731a24344f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118232731a24344f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANNX","BK4139"],"gpt_icon":0},{"id":"2483033765","title":"Annexon, Inc.盘中异动 早盘快速下跌5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483033765","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483033765?lang=zh_cn&edition=full","pubTime":"2024-11-13 00:16","pubTimestamp":1731428195,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日00时16分，Annexon, Inc.股票出现波动，股价快速下跌5.31%。Annexon, Inc.股票所在的生物技术行业中，整体跌幅为0.65%。Annexon, Inc.公司简介：Annexon Inc 是一家处于临床阶段的生物制药公司，为身体，大脑和眼部经典补体介导疾病患者开发新型疗法产品线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113001635a230f5d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113001635a230f5d6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANNX","BK4139"],"gpt_icon":0},{"id":"2480589043","title":"Annexon, Inc.盘中异动 大幅跳水5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480589043","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480589043?lang=zh_cn&edition=full","pubTime":"2024-11-04 22:40","pubTimestamp":1730731209,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日22时40分，Annexon, Inc.股票出现波动，股价大幅下跌5.36%。Annexon, Inc.股票所在的生物技术行业中，整体跌幅为0.23%。其相关个股中，Briacell Therapeutics Corp C/Wts 24/02/2025、Disc Medicine, Inc.、Neurogene Inc.涨幅较大，Nls Pharmaceutics Ltd.、Elevai Labs, Inc.、Gri Bio, Inc.较为活跃，换手率分别为247.47%、150.48%、49.20%，振幅较大的相关个股有Briacell Therapeutics Corp C/Wts 24/02/2025、Nls Pharmaceutics Ltd.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为29.83%、25.56%、22.67%。Annexon, Inc.公司简介：Annexon Inc 是一家处于临床阶段的生物制药公司，为身体，大脑和眼部经典补体介导疾病患者开发新型疗法产品线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110422401098e4049c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110422401098e4049c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANNX","BK4139"],"gpt_icon":0},{"id":"2474001873","title":"Annexon, Inc.盘中异动 早盘大幅拉升5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474001873","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474001873?lang=zh_cn&edition=full","pubTime":"2024-10-11 22:25","pubTimestamp":1728656701,"startTime":"0","endTime":"0","summary":"北京时间2024年10月11日22时25分，Annexon, Inc.股票出现异动，股价大幅拉升5.13%。Annexon, Inc.股票所在的生物技术行业中，整体涨幅为0.73%。其相关个股中，Conduit Pharmaceuticals Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 涨幅较大，Conduit Pharmaceuticals Inc.、Aditxt, Inc.、Gritstone Bio, Inc.较为活跃，换手率分别为199.32%、113.81%、19.57%，振幅较大的相关个股有Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Tc Biopharm  Plc C/Wts 10/02/2028 、Nutriband Inc C/Wts ，振幅分别为93.15%、70.00%、47.62%。Annexon, Inc.公司简介：Annexon Inc 是一家处于临床阶段的生物制药公司，为身体，大脑和眼部经典补体介导疾病患者开发新型疗法产品线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410112225019719fb06&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410112225019719fb06&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANNX","BK4139"],"gpt_icon":0},{"id":"2474427398","title":"Annexon, Inc.盘中异动 临近午盘股价大涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474427398","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474427398?lang=zh_cn&edition=full","pubTime":"2024-10-09 23:53","pubTimestamp":1728489194,"startTime":"0","endTime":"0","summary":"北京时间2024年10月09日23时53分，Annexon, Inc.股票出现异动，股价急速上涨5.08%。Annexon, Inc.股票所在的生物技术行业中，整体跌幅为0.16%。Annexon, Inc.公司简介：Annexon Inc 是一家处于临床阶段的生物制药公司，为身体，大脑和眼部经典补体介导疾病患者开发新型疗法产品线。公司的候选产品包括治疗自身免疫和神经退行性疾病的 ANX005，治疗眼科神经退行性疾病的 ANX007，口服小分子药物 ANX1502 以及治疗全身性自身免疫疾病的 ANX009。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410092353149719f4c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410092353149719f4c8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANNX"],"gpt_icon":0},{"id":"2473740884","title":"Annexon, Inc.盘中异动 大幅拉升5.15%报6.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2473740884","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473740884?lang=zh_cn&edition=full","pubTime":"2024-10-08 23:14","pubTimestamp":1728400441,"startTime":"0","endTime":"0","summary":"北京时间2024年10月08日23时14分，Annexon, Inc.股票出现波动，股价快速拉升5.15%。截至发稿，该股报6.46美元/股，成交量15.8955万股，换手率0.15%，振幅5.37%。Annexon, Inc.股票所在的生物技术行业中，整体跌幅为0.07%。Annexon, Inc.公司简介：Annexon Inc 是一家处于临床阶段的生物制药公司，为身体，大脑和眼部经典补体介导疾病患者开发新型疗法产品线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410082314029719f00f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410082314029719f00f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANNX","BK4139"],"gpt_icon":0},{"id":"2472252710","title":"Annexon, Inc.盘中异动 早盘急速拉升5.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472252710","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472252710?lang=zh_cn&edition=full","pubTime":"2024-10-02 22:51","pubTimestamp":1727880687,"startTime":"0","endTime":"0","summary":"北京时间2024年10月02日22时51分，Annexon, Inc.股票出现波动，股价大幅上涨5.40%。Annexon, Inc.股票所在的生物技术行业中，整体跌幅为0.58%。Annexon, Inc.公司简介：Annexon Inc 是一家处于临床阶段的生物制药公司，为身体，大脑和眼部经典补体介导疾病患者开发新型疗法产品线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410022251279719dfb3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410022251279719dfb3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANNX","BK4139"],"gpt_icon":0},{"id":"2470441884","title":"Annexon, Inc.盘中异动 股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2470441884","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470441884?lang=zh_cn&edition=full","pubTime":"2024-09-25 03:59","pubTimestamp":1727207944,"startTime":"0","endTime":"0","summary":"北京时间2024年09月25日03时59分，Annexon, Inc.股票出现波动，股价快速下跌5.04%。Annexon, Inc.股票所在的生物技术行业中，整体跌幅为0.44%。Annexon, Inc.公司简介：Annexon Inc 是一家处于临床阶段的生物制药公司，为身体，大脑和眼部经典补体介导疾病患者开发新型疗法产品线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240925035904ab65b050&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240925035904ab65b050&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANNX","BK4139"],"gpt_icon":0},{"id":"2469391149","title":"Annexon, Inc.盘中异动 早盘急速下挫5.12%报6.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2469391149","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469391149?lang=zh_cn&edition=full","pubTime":"2024-09-23 23:03","pubTimestamp":1727103792,"startTime":"0","endTime":"0","summary":"北京时间2024年09月23日23时03分，Annexon, Inc.股票出现波动，股价快速下跌5.12%。截至发稿，该股报6.67美元/股，成交量26.8577万股，换手率0.25%，振幅5.69%。Annexon, Inc.股票所在的生物技术行业中，整体跌幅为1.01%。Annexon, Inc.公司简介：Annexon Inc 是一家处于临床阶段的生物制药公司，为身体，大脑和眼部经典补体介导疾病患者开发新型疗法产品线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092323031298e38774&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092323031298e38774&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANNX","BK4139"],"gpt_icon":0},{"id":"2460065875","title":"Annexon, Inc.盘中异动 下午盘急速下跌5.05%报5.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2460065875","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460065875?lang=zh_cn&edition=full","pubTime":"2024-08-20 03:13","pubTimestamp":1724094813,"startTime":"0","endTime":"0","summary":"北京时间2024年08月20日03时13分，Annexon, Inc.股票出现波动，股价急速下挫5.05%。截至发稿，该股报5.79美元/股，成交量122.157万股，换手率1.16%，振幅8.20%。Annexon, Inc.股票所在的生物技术行业中，整体涨幅为1.50%。Annexon, Inc.公司简介：Annexon Inc 是一家处于临床阶段的生物制药公司，为身体，大脑和眼部经典补体介导疾病患者开发新型疗法产品线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082003133497199312&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082003133497199312&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANNX","BK4139"],"gpt_icon":0},{"id":"2459473765","title":"Annexon, Inc.盘中异动 快速拉升5.35%报5.91美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459473765","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459473765?lang=zh_cn&edition=full","pubTime":"2024-08-15 22:04","pubTimestamp":1723730673,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日22时04分，Annexon, Inc.股票出现波动，股价大幅上涨5.35%。截至发稿，该股报5.91美元/股，成交量7.699万股，换手率0.07%，振幅2.32%。Annexon, Inc.股票所在的生物技术行业中，整体涨幅为0.19%。Annexon, Inc.公司简介：Annexon Inc 是一家处于临床阶段的生物制药公司，为身体，大脑和眼部经典补体介导疾病患者开发新型疗法产品线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815220433ab5dd9e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815220433ab5dd9e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANNX","BK4139"],"gpt_icon":0},{"id":"2459107708","title":"Annexon, Inc.盘中异动 快速下跌5.01%报5.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459107708","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459107708?lang=zh_cn&edition=full","pubTime":"2024-08-15 00:43","pubTimestamp":1723653821,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日00时43分，Annexon, Inc.股票出现异动，股价大幅跳水5.01%。截至发稿，该股报5.40美元/股，成交量25.4212万股，换手率0.24%，振幅5.63%。Annexon, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。Annexon, Inc.公司简介：Annexon Inc 是一家处于临床阶段的生物制药公司，为身体，大脑和眼部经典补体介导疾病患者开发新型疗法产品线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815004341968263ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815004341968263ce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANNX","BK4139"],"gpt_icon":0},{"id":"2459110671","title":"美国研究综述-Agenus、Guardant Health、Zoetis","url":"https://stock-news.laohu8.com/highlight/detail?id=2459110671","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459110671?lang=zh_cn&edition=full","pubTime":"2024-08-14 14:49","pubTimestamp":1723618162,"startTime":"0","endTime":"0","summary":"    路透8月14日 - 华尔街证券分析师周三调整了对几家美国上市公司的评级和目标价，其中包括 Agenus、Guardant Health 和 Zoetis。要闻              * Agenus Inc   ：B. Riley将目标价从42美元下调至18美元             * Clorox   ：杰富瑞将目标价从 148 美元上调至 151 美元             * Guardant Health Inc   ：Raymond James将目标价从28美元上调至36美元             * 星巴克  ：Stifel将其评级从 \"持有 \"上调至 \"买入\"；将目标价从80美元上调至110美元             * Zoetis Inc   ：Piper Sandler将目标价从195美元上调至210美元 以下是路透周三报道的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BALL","EIX","IBTA","LU0942090050.USD","ANNX","FTHM","LU1363072403.SGD","AGEN","BOLD","CPK","IDXX","DUK","CNP","ETR","LU2211815571.USD","AMCX","FENC","LU0149725797.USD","MO","HEI","CTNM","ADVM","ATKR","FEMY","ALUR","HD","FE","BHF","CMS","LU2506952410.USD","WTRG","CLX","LU","LU0205193047.USD","AIZ","SKY","ED","EXC","AEP","LU2506952337.HKD","AWK","GH","SLRN","D","EMR","ES","BKH"],"gpt_icon":1},{"id":"2459967472","title":"Annexon, Inc.2024财年第二财季实现净利润-29.61百万美元，同比增加15.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459967472","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459967472?lang=zh_cn&edition=full","pubTime":"2024-08-13 08:00","pubTimestamp":1723507218,"startTime":"0","endTime":"0","summary":"8月13日，Annexon, Inc.公布财报，公告显示公司2024财年第二财季净利润为-29.61百万美元，同比增加15.86%；其中营业收入为0.00美元，每股基本收益为-0.23美元。从资产负债表来看，Annexon, Inc.总负债45.01百万美元，其中短期债务2.35百万美元，资产负债比为0.10，流动比率为0.22。机构评级：截至2024年8月13日，当前有6家机构对Annexon, Inc.目标价做出预测，其中目标均价为15.67美元，其中最低目标价为10.00美元，最高目标价为30.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408130800279593995d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408130800279593995d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANNX"],"gpt_icon":0},{"id":"2458982438","title":"Annexon Inc 报告截至一月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2458982438","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458982438?lang=zh_cn&edition=full","pubTime":"2024-08-12 23:03","pubTimestamp":1723475020,"startTime":"0","endTime":"0","summary":"   * Annexon Inc   公布的截至一月份的季度调整后每股亏损23美分，高于去年同期的每股-47美分。八位分析师对该季度的平均预期是每股亏损 23 美分。* Annexon Inc 公布的本季度每股收益为亏损 23 美分。* 该公司当季亏损 2961 万美元。* Annexon Inc 本季度股价上涨了 11.8%，今年迄今为止上涨了 20.7%。* 生物技术和医学研究同行的平均一致建议也是 \"买入\"。华尔街对 Annexon Inc 的 12 个月目标价中位数为 14.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Annexon Inc 报告截至一月的季度业绩 - 收益摘要","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ANNX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.annexonbio.com","stockEarnings":[{"period":"1week","weight":-0.1833},{"period":"1month","weight":-0.317},{"period":"3month","weight":-0.1222},{"period":"6month","weight":0.0423},{"period":"1year","weight":1.0598},{"period":"ytd","weight":0.1388}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0561},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.249}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Annexon, Inc.于2011年3月3日根据特拉华州法律注册成立。该公司是一家临床阶段生物制药公司，致力于开发针对经典补体介导的身体，大脑和眼睛疾病的新型疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.043018},{"month":2,"riseRate":0.5,"avgChangeRate":0.014392},{"month":3,"riseRate":0.25,"avgChangeRate":-0.117935},{"month":4,"riseRate":0.25,"avgChangeRate":-0.084387},{"month":5,"riseRate":0.75,"avgChangeRate":-0.02094},{"month":6,"riseRate":1,"avgChangeRate":0.11455},{"month":7,"riseRate":0.5,"avgChangeRate":0.138193},{"month":8,"riseRate":0.4,"avgChangeRate":-0.002079},{"month":9,"riseRate":0.8,"avgChangeRate":0.06228},{"month":10,"riseRate":0.2,"avgChangeRate":-0.092678},{"month":11,"riseRate":0.6,"avgChangeRate":0.02059},{"month":12,"riseRate":0.5,"avgChangeRate":0.128325}],"exchange":"NASDAQ","name":"Annexon, Inc.","nameEN":"Annexon, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Annexon, Inc.(ANNX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Annexon, Inc.(ANNX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Annexon, Inc.,ANNX,Annexon, Inc.股票,Annexon, Inc.股票老虎,Annexon, Inc.股票老虎国际,Annexon, Inc.行情,Annexon, Inc.股票行情,Annexon, Inc.股价,Annexon, Inc.股市,Annexon, Inc.股票价格,Annexon, Inc.股票交易,Annexon, Inc.股票购买,Annexon, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Annexon, Inc.(ANNX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Annexon, Inc.(ANNX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}